• Je něco špatně v tomto záznamu ?

The tumor immune microenvironment and its implications for clinical outcome in patients with oropharyngeal squamous cell carcinoma

D. Gurin, M. Slavik, M. Hermanova, I. Selingerova, T. Kazda, M. Hendrych, T. Shatokhina, M. Vesela,

. 2020 ; 49 (9) : 886-896. [pub] 20200702

Jazyk angličtina Země Dánsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20027778

Grantová podpora
00209805 Ministry of Health, Czech Republic

BACKGROUND: We examined PD-L1 expression on tumor cells (TCs) and immune cells (ICs) and density of CD3+ and CD8+ tumor-infiltrating lymphocytes (TILs) in patients with oropharyngeal squamous cell carcinoma (OPSCC) and investigated their significance on clinicopathological characteristics and clinical outcomes. METHODS: In a cohort of 65 patients treated by definitive intensity-modulated radiotherapy (IMRT) with curative intent, immunohistochemical analysis of PD-L1 expression on TCs and ICs, and TIL subtyping was performed on primary biopsy tumor tissues, followed by prognostic evaluation of these immune response-related parameters including classification into four tumor immune microenvironment (TIM) types. To evaluate HPV status, p16 immunohistochemistry was performed. RESULTS: Densities of CD3+ and CD8+ TILs and PD-L1 expressions on TCs and ICs were significantly higher in p16+/HPV-mediated OPSCC. Patients with high densities of stromal CD8+ TILs displayed significantly better overall survival (OS) and progression-free survival (PFS). PD-L1 expression neither on tumor cells nor on immune cells affected survival outcomes. Distribution of TIM types based on the combination of PD-L1 expression on TCs and densities of CD8+ TILs is significantly different in p16+ compared with p16- OPSCC. In type III TIM (TC-PD-L1+/low CD8+ TIL density), significantly better OS was shown in p16+ group compared with p16- OPSCC. CONCLUSION: The prognostic and predictive role of tumor immune microenvironment was confirmed for patients with OPSCC. Combining HPV status with the evaluation of densities of CD8+ TILs and PD-L1 expression including TIM classification might be of high clinical interest and warrants further prospective evaluation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20027778
003      
CZ-PrNML
005      
20210114152339.0
007      
ta
008      
210105s2020 dk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/jop.13055 $2 doi
035    __
$a (PubMed)32516834
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a dk
100    1_
$a Gurin, Dominik $u First Department of Pathology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
245    14
$a The tumor immune microenvironment and its implications for clinical outcome in patients with oropharyngeal squamous cell carcinoma / $c D. Gurin, M. Slavik, M. Hermanova, I. Selingerova, T. Kazda, M. Hendrych, T. Shatokhina, M. Vesela,
520    9_
$a BACKGROUND: We examined PD-L1 expression on tumor cells (TCs) and immune cells (ICs) and density of CD3+ and CD8+ tumor-infiltrating lymphocytes (TILs) in patients with oropharyngeal squamous cell carcinoma (OPSCC) and investigated their significance on clinicopathological characteristics and clinical outcomes. METHODS: In a cohort of 65 patients treated by definitive intensity-modulated radiotherapy (IMRT) with curative intent, immunohistochemical analysis of PD-L1 expression on TCs and ICs, and TIL subtyping was performed on primary biopsy tumor tissues, followed by prognostic evaluation of these immune response-related parameters including classification into four tumor immune microenvironment (TIM) types. To evaluate HPV status, p16 immunohistochemistry was performed. RESULTS: Densities of CD3+ and CD8+ TILs and PD-L1 expressions on TCs and ICs were significantly higher in p16+/HPV-mediated OPSCC. Patients with high densities of stromal CD8+ TILs displayed significantly better overall survival (OS) and progression-free survival (PFS). PD-L1 expression neither on tumor cells nor on immune cells affected survival outcomes. Distribution of TIM types based on the combination of PD-L1 expression on TCs and densities of CD8+ TILs is significantly different in p16+ compared with p16- OPSCC. In type III TIM (TC-PD-L1+/low CD8+ TIL density), significantly better OS was shown in p16+ group compared with p16- OPSCC. CONCLUSION: The prognostic and predictive role of tumor immune microenvironment was confirmed for patients with OPSCC. Combining HPV status with the evaluation of densities of CD8+ TILs and PD-L1 expression including TIM classification might be of high clinical interest and warrants further prospective evaluation.
650    _2
$a CD8-pozitivní T-lymfocyty $7 D018414
650    12
$a nádory hlavy a krku $7 D006258
650    _2
$a lidé $7 D006801
650    _2
$a tumor infiltrující lymfocyty $7 D016246
650    12
$a nádory orofaryngu $7 D009959
650    _2
$a prognóza $7 D011379
650    _2
$a dlaždicobuněčné karcinomy hlavy a krku $7 D000077195
650    _2
$a nádorové mikroprostředí $7 D059016
655    _2
$a časopisecké články $7 D016428
700    1_
$a Slavik, Marek $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic. Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Hermanova, Marketa $u First Department of Pathology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. First Department of Pathology, St. Anne's University Hospital, Brno, Czech Republic.
700    1_
$a Selingerova, Iveta $u Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
700    1_
$a Kazda, Tomas $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic. Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
700    1_
$a Hendrych, Michal $u First Department of Pathology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. First Department of Pathology, St. Anne's University Hospital, Brno, Czech Republic.
700    1_
$a Shatokhina, Tetiana $u First Department of Pathology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. First Department of Pathology, St. Anne's University Hospital, Brno, Czech Republic.
700    1_
$a Vesela, Marcela $u First Department of Pathology, St. Anne's University Hospital, Brno, Czech Republic.
773    0_
$w MED00007685 $t Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology $x 1600-0714 $g Roč. 49, č. 9 (2020), s. 886-896
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32516834 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114152337 $b ABA008
999    __
$a ok $b bmc $g 1608113 $s 1118958
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 49 $c 9 $d 886-896 $e 20200702 $i 1600-0714 $m Journal of oral pathology & medicine $n J Oral Pathol Med $x MED00007685
GRA    __
$a 00209805 $p Ministry of Health, Czech Republic
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Možnosti archivace